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HIV: Dendritic cells as embers for the infectious fire
Edward A. Clark
In people with HIV-1, most of the CD4-expressing T
cells that produce virus are short-lived and vulnerable
to anti-retroviral agents. But the initial ‘fire’ of HIV-1
infection may begin in, and be maintained by, cells of
the dendritic cell lineage.
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More than 99 % of HIV-1 in infected individuals is pro-
duced by recently infected and short-lived T cells which
express the cell-surface marker CD4 [1–3]. Although anti-
retroviral agents can effectively block the ‘raging fire’ [1]
of HIV-1 replication in T cells, it is less clear how to
prevent viral persistence in long-lived cell populations —
potential reservoirs that could re-ignite the fire.
Several recent studies suggest that cells within the den-
dritic cell (DC) lineage may be a key reservoir for active
HIV-1 replication. DCs are a heterogeneous family of
highly efficient antigen-processing and antigen-presenting
cells that interact with T cells. Like T-cell subsets, the
different family members are classified on the basis of
their characteristic expression of cellular markers. For
instance, epidermal Langerhans cells (LCs) are classified
as S100+,CD1a+,factor XIIIa– ; DCs found in the mucosal
interstitium and epithelium are classed as S100+,CD1a–,
factor XIIIa+ [4]. DCs found in the regions of peripheral
lymphoid tissues that are populated by T cells express
costimulatory molecules, such as CD80 (B7-1) and CD86
(B7-2), which are required to activate resting T cells. The
relationship between these cell types has not been
defined precisely, but they are likely to be dendritic-
lineage subsets at different stages of maturation. Upon
exposure of skin LCs to antigen, the antigen is processed
by the cells. Cytokines, such as tumor necrosis factor-a
[5], then induce the LCs to mature into DCs, which then
migrate into the lamina propria (the layer of connective
tissue underlying the epithelium of a mucous membrane)
or to the lymph nodes, where they encounter and activate
antigen-specific T cells. Cells within the dendritic lineage
express CD4, the receptor for HIV, and thus are poten-
tially capable of binding HIV and/or being infected by it.
Precisely where the initial and active sites for HIV-1 repli-
cation lie remains controversial. It is clear that skin LCs
can be infected with HIV-1, and it may well be that LCs
are an initial target of HIV infection [6,7]. But it has been
less clear whether DCs are efficiently infected by HIV-1
in vivo. Recently, by examining adenoidal lymphoid tissue
from asymptomatic HIV-1-infected individuals, Frankel
and coworkers [8] discovered ‘giant cells’ within, and just
beneath, the mucosa that contained HIV-1 genomes and
intracellular viral p24 antigen. These syncytia — which
were actively replicating HIV-1 in otherwise asympto-
matic people — expressed the DC marker, S100, and an
actin-bundling protein, p55, which is known to be
expressed in DCs. These results suggested that the syncy-
tia may be made up of cells that include DCs. Because
LCs may mature into DCs, and because LC preparations
are likely to contain DCs as well, it is possible that some of
the HIV-1 production previously ascribed to LCs may
actually be attributable to DCs. And because DCs, unlike
LCs, interact with T cells in vivo, Frankel and coworkers
[8] proposed that interactions between DCs and T cells in
mucosal lymphoid tissues ‘‘may drive HIV-1 replication’’.
These striking in vivo data are not sufficient by them-
selves to implicate DCs as a key reservoir of HIV-1 infec-
tion. Neither S100 nor p55 is found only in DCs; p55, for
example, is also expressed in activated B cells. Although
the authors suggest [8] that T cells may be contributing to
the giant syncytia, they have not tested this directly (as
yet). However, the model is also consistent with results
from several previous studies. HIV RNA transcripts have
been detected in situ within CD4+,factor XIIIa+ dermal
DCs [9]. Cutaneous CD4+ DCs can also be infected by
HIV-1 in vitro [10,11]. Furthermore, a mixture of DC and
CD4+ T cells promotes extensive HIV-1 expression and
spread [12–15] via a process that requires interactions
between the DCs and CD4+ T cells [13]. Interestingly,
HIV-1-pulsed DCs may maintain HIV-1 longer than
HIV-1-pulsed T cells or monocytes [10,14], consistent
with a model suggesting that DCs are the ‘embers’ that
can ignite or re-ignite the HIV-1 fire.
DCs may also be an initial target early in simian immuno-
deficiency virus (SIV) infection. Spira and coworkers [15]
found that within days of inoculating macaques intravagi-
nally with SIV, SIV-infected cells were present in the
vaginal lamina propria that appeared to be non-lymphoid
cells expressing S100 and major histocompatibility complex
class (MHC) II molecules. The cells were most probably
DCs, because although LCs express the same markers,
they do not reside in this site [15]. There is also evidence
for the involvement of dendritic-lineage cells early in
HIV-1 infections. Sexual transmission of HIV-1 seems to
be subtype-selective, because certain relatively rare vari-
ants are preferentially transmitted sexually (see [15]). For
example, a recent study [16] suggests that HIV-1 infection
may be most efficiently transmitted via heterosexual routes
by isolates that grow preferentially in dendritic lineage
cells. In this study [16], the authors compared HIV-1
subtypes isolated from American homosexuals with those
isolated from Thai heterosexuals [16]. All of the isolates
from the heterosexuals were subtype E and grew effi-
ciently in LCs, whereas all of the typed isolates from the
homosexuals were subtype B and grew less well in LCs
than the subtype E isolates. In Thai heterosexual couples
where one partner was HIV-1-positive and the other was
HIV-1-negative, transmission was more efficient where
subtype E viruses were involved [17]. The selective
tropism for LCs measured in vitro may reflect a similar
tropism for DCs; indeed, it is likely that the LC prepara-
tions of Soto-Ramirez et al. [16] also contain DCs. Trans-
mission by homosexual routes could also involve DCs, as
functional dendritic-lineage cells are present in the colonic
epithelium (see, for example [18]). It remains to be deter-
mined whether HIV-1 subtypes differ in their ability to
infect LCs and DCs, or in their requirement for these cells
during the infection of CD4+ T cells.
Why might DC-containing syncytia in particular be espe-
cially productive sites of HIV-1 replication in vivo? Studies
in vitro suggest that a syncytium of DCs and T cells might
express a combination of factors promoting efficient HIV
replication that is not produced by either cell alone.
Granelli-Piperno et al. [19] found that DCs do not express
the transcription factor Sp1 but that T cells do; in contrast,
resting T cells do not express NF-kB-related proteins
such as p50 and p65, but DCs do. The syncytia contain
both Sp1 and NF-kB, implying that they may express a
combination of transcriptional activators capable of stimu-
lating HIV-1 replication, and that this combination is not
produced by T cells or DCs alone. But further analysis is
needed to determine whether the HIV-producing syncytia
found in vivo [8] are a fusion of DCs and T cells — and
any model proposing that such syncytia are vital for the
spread of HIV-1 must consider that syncytia may be
‘terminal’ cells with relatively short life spans.
What signals might ‘stoke’ DCs and lead them to produce
HIV-1 efficiently, or to be more effective antigen-present-
ing cells in promoting HIV-1 spread? Culturing DCs alone
with HIV-1 leads to little or no viral production, whereas
culturing HIV-1-pulsed DCs together with CD4+ T cells
leads to significant viral production [11–13,20]. Interactions
between DCs and T cells that occur during antigen presen-
tation may be critical for HIV activation and transmission,
as suggested by the finding that PPD (purified protein
derivative of tuberculin) [20] or specific antigen [21] can
significantly augment HIV-1 production mediated by DCs
and T cells. Stimulating DCs via the CD40L–CD40 acces-
sory receptor pathway [13] has a similar effect. The stage of
maturation may also affect the ability of DCs to retain or
replicate HIV-1; Weissman et al. [14], for instance, found
that one blood DC subset could be infected with HIV-1,
whereas another subset could not, even though both
subsets could bind HIV. Conversely, agents that reduce
DCs’ antigen-presenting activity, arrest DC maturation, or
induce apoptosis of DCs, may prevent DC-dependent
HIV-1 production. For example, the antigen-presenting
function of LCs is downregulated by an epidermal nerve
product, calcitonin gene-related peptide [22]. Furthermore,
blocking the DC–T-cell interactions mediated by CD80
and CD86 in vitro also blocks DC-dependent HIV-1 pro-
duction [12]. Interleukin-10 (IL-10) can also block the
interaction between DCs and T cells by downregulating
the expression of the key CD86 costimulatory molecule on
DCs [23]; IL-10 can also accelerate apoptosis in DCs [24].
Thus, dendritic-lineage cells may not only act as a latent
reservoir for HIV genomes, but upon contact with antigen-
specific T cells, they may also initiate a process depen-
dent on DC–T-cell interactions, leading to bursts of HIV
production, particularly in DC–T-cell syncytia. According
to this model, latently infected DCs may be the ‘embers’
and DC–T-cell interactions the ‘bellows’ that fuel active
short-lived production of HIV. Clearly, defining more
fully how the life span and antigen-presenting activity of
dendritic-lineage cells are regulated will be key areas of
future investigation for those hoping to put the HIV fire
out completely.
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